Complement 1, a NYC-based health tech startup improving cancer care through personalized lifestyle medicine, raised $16M in Seed funding.
The round was led by Owl Ventures and Blume Ventures.
The company intends to use the funds to expand operations and its R&D efforts.
Led by CEO Karan Bajaj, Complement 1 is a health technology company dedicated to improving cancer care through lifestyle medicine. It has developed a tech-enabled lifestyle program with daily 1:1 dedicated CoActive Coaching for cancer patients, survivors, and those at high risk. By combining personalized coaching with evidence-based interventions in physical activity, nutrition, and somatic practices, the company helps patients improve outcomes and quality of life while reducing costs for employers, providers, and insurers.
Its platform integrates with conventional oncology care to deliver better outcomes and empower patients in their healing journey.
FinSMEs
13/05/2025